Medications for Anaphylaxis

53 results

  • Adrenalin (epinephrine)

    (epinephrine)
    Par Pharmaceutical, Inc.
    Usage: The drug is indicated for the emergency treatment of allergic reactions, including anaphylaxis from various triggers, and to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.

  • Adrenalin (epinephrine) (adrenalin (epinephrine))

    (ADRENALIN (EPINEPHRINE))
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: Adrenalin® is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis triggered by various allergens such as insect stings, foods, and medications. It addresses symptoms like hypotension, airway swelling, and bronchospasm. Available in 1 mL and 30 mL vials for intramuscular or subcutaneous use.

  • Auvi-q

    (epinephrine)
    kaleo, Inc
    Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis due to insect stings, food, medications, and other allergens. It is intended for immediate self-administration in individuals at risk for anaphylaxis and is not a substitute for medical care.

  • Auvi-q (auvi-q)

    (AUVI-Q)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis from stinging and biting insects, foods, drugs, allergen immunotherapy, and other allergens. It is intended for immediate self-administration in individuals at increased risk for anaphylaxis and is not a substitute for medical care.

  • Auvi-q (auvi-q)

    (AUVI-Q)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis from stinging/biting insects, foods, drugs, and other allergens. It is intended for immediate self-administration in patients at increased risk for anaphylaxis and is not a replacement for medical care.

  • Auvi-q (auvi-q)

    (AUVI-Q)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis from various allergens (e.g., stinging and biting insects, foods, drugs). It is for patients at increased risk for anaphylaxis and is intended for immediate self-administration, not as a substitute for medical care.

  • Carbinoxamine maleate (carbinoxamine maleate)

    (CARBINOXAMINE MALEATE)
    Foxland Pharmaceuticals, Inc.
    Usage: Carbinoxamine maleate is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, dermatographism, and as an adjunct therapy for anaphylactic reactions after acute symptoms have been controlled. It also helps reduce allergic reaction severity to blood or plasma.

  • Cyproheptadine hydrochloride (cyproheptadine hydrochloride)

    (Cyproheptadine Hydrochloride)
    Boscogen, Inc.
    Usage: The drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin manifestations (urticaria and angioedema), cold urticaria, dermatographism, and as adjunctive therapy for anaphylactic reactions following initial treatment.

  • Cyproheptadine hydrochloride (cyproheptadine hydrochloride)

    (Cyproheptadine Hydrochloride)
    VistaPharm, LLC
    Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions (urticaria and angioedema), ameliorating allergic reactions to blood or plasma, cold urticaria, and dermatographism. It is also used as adjunctive therapy for anaphylactic reactions.

  • Cyproheptadine hydrochloride (cyproheptadine hydrochloride)

    (Cyproheptadine Hydrochloride)
    Rising Pharma Holdings, Inc.
    Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, ameliorating allergic reactions to blood, and as an adjunctive therapy for anaphylactic reactions after acute management.